CELG Market Cap History



Below is a table of the CELG market cap history going back to 2/11/2010:

Date CELG Market Cap
2/11/201026.28B
4/23/201027.56B
7/23/201024.24B
10/26/201027.88B
2/18/201124.86B
4/27/201127.31B
10/25/201129.25B
2/16/201233.13B
4/25/201234.32B
7/23/201228.38B
10/19/201231.79B
12/31/201232.86B
4/23/201352.56B
7/23/201355.56B
10/22/201366.28B
2/7/201463.70B
4/21/201457.59B
6/26/201469.37B
7/22/201469.29B
10/21/201475.85B
2/12/201592.64B
4/24/201594.15B
7/24/2015106.64B
10/30/201596.41B
2/5/201676.52B
4/26/201683.31B
7/22/201683.34B
10/21/201676.68B
2/3/201789.96B
4/20/201796.25B
7/21/2017107.76B
10/23/201796.34B
2/2/201875.07B
4/23/201864.86B
7/23/201859.84B
10/22/201856.37B
2/21/201962.25B
2/27/201963.91B
4/22/201965.89B
7/26/201965.74B
10/29/201975.66B

Also see: CELG Shares Outstanding History
and CELG YTD Return
CELG Historical Market Cap:
+11.50% CAGR
CELG Historical Market Cap: +11.50% CAGR

Mouse over chart for data details
2/11/2010 ...10/29/2019
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s pharmaceutical products include chemically-synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor T-cell therapies. Co.'s primary product includes Eliquis® - Eliquis (apixaban), which is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy. We show 41 historical shares outstanding datapoints in our CELG shares outstanding history coverage, used to compute CELG market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CELG market cap history over the course of time is important for investors interested in comparing CELG's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CELG versus a peer is one thing; comparing CELG market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CELG can fluctuate over the course of history. With this page we aim to empower investors researching CELG by allowing them to research the CELG market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CELG Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Celgene (CELG) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CELL Market Cap History
CELZ Market Cap History
CEMI Market Cap History
CERC Market Cap History
CERE Market Cap History
CERS Market Cap History
CFMS Market Cap History
CFRX Market Cap History
CGEM Market Cap History
CGEN Market Cap History
More Healthcare companies »

 

CELG Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.